PDT Partners’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $121K | Buy |
+18,896
| New | +$121K | 0.01% | 665 |
|
2024
Q3 | – | Sell |
-46,382
| Closed | -$316K | – | 749 |
|
2024
Q2 | $316K | Buy |
+46,382
| New | +$316K | 0.03% | 543 |
|
2022
Q4 | – | Sell |
-16,873
| Closed | -$354K | – | 707 |
|
2022
Q3 | $354K | Sell |
16,873
-24,993
| -60% | -$524K | 0.05% | 535 |
|
2022
Q2 | $1.3M | Buy |
41,866
+15,169
| +57% | +$471K | 0.11% | 306 |
|
2022
Q1 | $1.1M | Buy |
+26,697
| New | +$1.1M | 0.09% | 338 |
|
2015
Q4 | – | Sell |
-10,989
| Closed | -$313K | – | 547 |
|
2015
Q3 | $313K | Buy |
+10,989
| New | +$313K | 0.01% | 1040 |
|
2014
Q4 | – | Sell |
-17,096
| Closed | -$364K | – | 751 |
|
2014
Q3 | $364K | Sell |
17,096
-7,104
| -29% | -$151K | 0.01% | 1046 |
|
2014
Q2 | $544K | Buy |
24,200
+4,600
| +23% | +$103K | 0.01% | 954 |
|
2014
Q1 | $495K | Buy |
+19,600
| New | +$495K | 0.01% | 955 |
|